GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 133 filers reported holding GOSSAMER BIO INC in Q2 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $77,683 | +24.5% | 64,736 | +30.7% | 0.00% | – |
| Q1 2023 | $62,410 | -50.4% | 49,532 | -13.3% | 0.00% | – |
| Q4 2022 | $125,823 | -59.1% | 57,112 | +122.5% | 0.00% | – |
| Q3 2022 | $307,551 | +38.6% | 25,672 | -3.1% | 0.00% | – |
| Q2 2022 | $221,847 | -5.7% | 26,505 | -2.2% | 0.00% | – |
| Q1 2022 | $235,237 | -37.8% | 27,101 | -18.9% | 0.00% | – |
| Q4 2021 | $378,000 | -14.1% | 33,426 | -4.6% | 0.00% | – |
| Q3 2021 | $440,000 | +41.5% | 35,030 | -8.5% | 0.00% | – |
| Q2 2021 | $311,000 | -4.9% | 38,294 | +8.3% | 0.00% | – |
| Q1 2021 | $327,000 | -4.4% | 35,370 | +0.0% | 0.00% | – |
| Q4 2020 | $342,000 | -14.7% | 35,360 | +9.3% | 0.00% | – |
| Q3 2020 | $401,000 | +5.0% | 32,337 | +6.8% | 0.00% | – |
| Q2 2020 | $382,000 | +32.2% | 30,282 | +6.5% | 0.00% | – |
| Q1 2020 | $289,000 | -30.4% | 28,442 | +7.2% | 0.00% | – |
| Q4 2019 | $415,000 | -9.2% | 26,536 | -0.1% | 0.00% | -100.0% |
| Q3 2019 | $457,000 | +65.6% | 26,574 | +113.5% | 0.00% | – |
| Q2 2019 | $276,000 | – | 12,449 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 3,370,000 | $4,044,000 | 0.97% |
| Octagon Capital Advisors LP | 3,958,069 | $4,749,683 | 0.66% |
| Palo Alto Investors LP | 3,465,152 | $4,158,182 | 0.34% |
| NEA Management Company, LLC | 3,467,406 | $4,160,887 | 0.32% |
| APIS CAPITAL ADVISORS, LLC | 180,000 | $216,000 | 0.22% |
| Boxer Capital, LLC | 3,336,928 | $4,004 | 0.19% |
| HHLR ADVISORS, LTD. | 4,974,041 | $5,968,849 | 0.13% |
| Artal Group S.A. | 3,028,171 | $3,634 | 0.11% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 2,363,170 | $2,835,804 | 0.10% |
| Birchview Capital, LP | 99,088 | $118,906 | 0.09% |